Old Mission Capital LLC Mirati Therapeutics, Inc. Transaction History

Old Mission Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$75.82 - $150.97 $1.37 Million - $2.73 Million	-18,054 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$132.01 - $190.29 $2.38 Million - $3.44 Million	18,054 New	18,054 $2.65 Million
Q2 2021 Aug 13, 2021	SELL	$144.0 - $179.73 $296,928 - $370,603	-2,062 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$158.92 - $221.61 $327,693 - $456,959	2,062 New	2,062 $353,000
Q2 2020 Aug 12, 2020	SELL	$72.01 - $120.39 $873,337 - $1.46 Million	-12,128 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $846,291 - $1.41 Million	12,128 New	12,128 $932,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.